The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Extracellular Vesicles Improve Post-Stroke Neuroregeneration and Prevent Postischemic Immunosuppression
Open accessAbstract
Although the initial concepts of stem cell therapy aimed at replacing lost tissue, more recent evidence has suggested that stem and progenitor cells alike promote postischemic neurological recovery by secreted factors that restore the injured brain's capacity to reshape. Specifically, extracellular vesicles (EVs) derived from stem cells such as exosomes have recently been suggested to mediate restorative stem cell effects. In order to define whether EVs indeed improve postischemic neurological impairment and brain remodeling, we systematically compared the effects of mesenchymal stem cell (MSC)-derived EVs (MSC-EVs) with MSCs that were i.v. delivered to mice on days 1, 3, and 5 (MSC-EVs) or on day 1 (MSCs) after focal cerebral ischemia in C57BL6 mice. For as long as 28 days after stroke, motor coordination deficits, histological brain injury, immune responses in the peripheral blood and brain, and cerebral angiogenesis and neurogenesis were analyzed. Improved neurological impairment and long-term neuroprotection associated with enhanced angioneurogenesis were noticed in stroke mice receiving EVs from two different bone marrow-derived MSC lineages. MSC-EV administration closely resembled responses to MSCs and persisted throughout the observation period. Although cerebral immune cell infiltration was not affected by MSC-EVs, postischemic immunosuppression (i.e., B-cell, natural killer cell, and T-cell lymphopenia) was attenuated in the peripheral blood at 6 days after ischemia, providing an appropriate external milieu for successful brain remodeling. Because MSC-EVs have recently been shown to be apparently safe in humans, the present study provides clinically relevant evidence warranting rapid proof-of-concept studies in stroke patients. Significance: Transplantation of mesenchymal stem cells (MSCs) offers an interesting adjuvant approach next to thrombolysis for treatment of ischemic stroke. However, MSCs are not integrated into residing neural networks but act indirectly, inducing neuroprotection and promoting neuroregeneration. Although the mechanisms by which MSCs act are still elusive, recent evidence has suggested that extracellular vesicles (EVs) might be responsible for MSC-induced effects under physiological and pathological conditions. The present study has demonstrated that EVs are not inferior to MSCs in a rodent stroke model. EVs induce long-term neuroprotection, promote neuroregeneration and neurological recovery, and modulate peripheral post-stroke immune responses. Also, because EVs are well-tolerated in humans, as previously reported, the administration of EVs under clinical settings might set the path for a novel and innovative therapeutic stroke concept without the putative side effects attached to stem cell transplantation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Valadi, H., Ekström, K., Bossios, A., Sjöstrand, M., Lee, J. J., & Lötvall, J. O. (2007) · Nature Cell Biology · doi:10.1038/ncb1596 · Cited by 12,834
Isolation and Characterization of Exosomes from Cell Culture Supernatants and Biological Fluids
Théry, C., Amigorena, S., Raposo, G., & Clayton, A. (2006) · Current Protocols in Cell Biology · doi:10.1002/0471143030.cb0322s30 · Cited by 5,766
Mesenchymal stem cells in health and disease
Uccelli, A., Moretta, L., & Pistoia, V. (2008) · Nature Reviews Immunology · doi:10.1038/nri2395 · Cited by 3,746
Le Blanc, K., Rasmusson, I., Sundberg, B., Götherström, C., Hassan, M., Uzunel, M., & Ringdén, O. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16104-7 · Cited by 2,734
Witwer, K. W., Buzás, E. I., Bemis, L. T., Bora, A., Lässer, C., Lötvall, J., Nolte‐‘t Hoen, E. N., Piper, M. G., Sivaraman, S., Skog, J., et al. (2013) · Journal of Extracellular Vesicles · doi:10.3402/jev.v2i0.20360 · Cited by 2,421
Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury
Lai, R. C., Arslan, F., Lee, M. M., Sze, N. S. K., Choo, A., Chen, T. S., Salto-Tellez, M., Timmers, L., Lee, C. N., El Oakley, R. M., et al. (2010) · Stem Cell Research · doi:10.1016/j.scr.2009.12.003 · Cited by 2,215
Adult mesenchymal stem cells for tissue engineering versus regenerative medicine
Caplan, A. I. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21200 · Cited by 1,956
Lee, R. H., Pulin, A. A., Seo, M. J., Kota, D. J., Ylostalo, J., Larson, B. L., Semprun-Prieto, L., Delafontaine, P., & Prockop, D. J. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2009.05.003 · Cited by 1,898
Chen, J., Li, Y., Wang, L., Zhang, Z., Lu, D., Lu, M., & Chopp, M. (2001) · Stroke · doi:10.1161/01.str.32.4.1005 · Cited by 1,764
Caplan, A. I., & Correa, D. (2011) · Cell Stem Cell · doi:10.1016/j.stem.2011.06.008 · Cited by 1,682
Stroke-Associated Pneumonia: Major Advances and Obstacles
Hannawi, Y., Hannawi, B., Rao, C. P. V., Suarez, J. I., & Bershad, E. M. (2013) · Cerebrovascular Diseases · doi:10.1159/000350199 · Cited by 1,656
MSC-derived exosomes: a novel tool to treat therapy-refractory graft-versus-host disease
Kordelas, L., Rebmann, V, Ludwig, A.-K., Radtke, S., Ruesing, J., Doeppner, T. R., Epple, M., Horn, P. A., Beelen, D. W., & Giebel, B. (2014) · Leukemia · doi:10.1038/leu.2014.41 · Cited by 1,084
Self-citationTemporal and Spatial Dynamics of Cerebral Immune Cell Accumulation in Stroke
Gelderblom, M., Leypoldt, F., Steinbach, K., Behrens, D., Choe, C.-U., Siler, D. A., Arumugam, T. V., Orthey, E., Gerloff, C., Tolosa, E., et al. (2009) · Stroke · doi:10.1161/strokeaha.108.534503 · Cited by 1,066
Xin, H., Li, Y., Cui, Y., Yang, J. J., Zhang, Z. G., & Chopp, M. (2013) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2013.152 · Cited by 984
Central nervous system injury-induced immune deficiency syndrome
Meisel, C., Schwab, J. M., Prass, K., Meisel, A., & Dirnagl, U. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1765 · Cited by 968
Sokolova, V., Ludwig, A.-K., Hornung, S., Rotan, O., Horn, P. A., Epple, M., & Giebel, B. (2011) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2011.05.013 · Cited by 851
Self-citationExosomes Derived from Human Umbilical Cord Mesenchymal Stem Cells Alleviate Liver Fibrosis
Li, T., Yan, Y., Wang, B., Qian, H., Zhang, X., Shen, L., Wang, M., Zhou, Y., Zhu, W., Li, W., et al. (2013) · Stem Cells and Development · doi:10.1089/scd.2012.0395 · Cited by 850
Gatti, S., Bruno, S., Deregibus, M. C., Sordi, A., Cantaluppi, V., Tetta, C., & Camussi, G. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfr015 · Cited by 813
Effect of brain edema on infarct volume in a focal cerebral ischemia model in rats.
Lin, T. N., He, Y. Y., Wu, G., Khan, M., & Hsu, C. Y. (1993) · Stroke · doi:10.1161/01.str.24.1.117 · Cited by 722
Reduction of myocardial infarct size by human mesenchymal stem cell conditioned medium
Timmers, L., Lim, S. K., Arslan, F., Armstrong, J. S., Hoefer, I. E., Doevendans, P. A., Piek, J. J., El Oakley, R. M., Choo, A., Lee, C. N., et al. (2008) · Stem Cell Research · doi:10.1016/j.scr.2008.02.002 · Cited by 617
Stroke and the immune system: from pathophysiology to new therapeutic strategies
Macrez, R., Ali, C., Toutirais, O., Le Mauff, B., Defer, G., Dirnagl, U., & Vivien, D. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70066-7 · Cited by 560
Exosomes: Small vesicles participating in intercellular communication
Ludwig, A.-K., & Giebel, B. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2011.10.005 · Cited by 537
Self-citationExperimental Stroke Induces Massive, Rapid Activation of the Peripheral Immune System
Offner, H., Subramanian, S., Parker, S. M., Afentoulis, M. E., Vandenbark, A. A., & Hurn, P. D. (2006) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600217 · Cited by 536
Cantaluppi, V., Gatti, S., Medica, D., Figliolini, F., Bruno, S., Deregibus, M. C., Sordi, A., Biancone, L., Tetta, C., & Camussi, G. (2012) · Kidney International · doi:10.1038/ki.2012.105 · Cited by 535
Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke
Honmou, O., Houkin, K., Matsunaga, T., Niitsu, Y., Ishiai, S., Onodera, R., Waxman, S. G., & Kocsis, J. D. (2011) · Brain · doi:10.1093/brain/awr063 · Cited by 494
Stroke-Induced Immunodepression: Experimental Evidence and Clinical Relevance
Dirnagl, U., Klehmet, J., Braun, J. S., Harms, H., Meisel, C., Ziemssen, T., Prass, K., & Meisel, A. (2007) · Stroke · doi:10.1161/01.str.0000251441.89665.bc · Cited by 473
The Tumorigenicity of Human Embryonic Stem Cells
(2008) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)00005-5 · Cited by 451
Mesenchymal stem cells: a double-edged sword in regulating immune responses
Li, W., Ren, G., Huang, Y., Su, J., Han, Y., Li, J., Chen, X., Cao, K., Chen, Q., Shou, P., et al. (2012) · Cell Death & Differentiation · doi:10.1038/cdd.2012.26 · Cited by 435
Therapeutic benefit of bone marrow stromal cells administered 1 month after stroke
Shen, L. H., Li, Y., Chen, J., Zacharek, A., Gao, Q., Kapke, A., Lu, M., Raginski, K., Vanguri, P., Smith, A., et al. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600311 · Cited by 353
Bacigaluppi, M., Pluchino, S., Jametti, L. P., Kilic, E., Kilic, Ü., Salani, G., Brambilla, E., West, M. J., Comi, G., Martino, G., et al. (2009) · Brain · doi:10.1093/brain/awp174 · Cited by 350
Self-citationHermann, D. M., & Chopp, M. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70039-x · Cited by 333
Self-citationHsieh, J.-Y., Wang, H.-W., Chang, S.-J., Liao, K.-H., Lee, I.-H., Lin, W.-S., Wu, C.-H., Lin, W.-Y., & Cheng, S.-M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072604 · Cited by 318
Intravenous autologous bone marrow mononuclear cells for ischemic stroke
Savitz, S. I., Misra, V., Kasam, M., Juneja, H., Cox, C. S., Alderman, S., Aisiku, I., Kar, S., Gee, A., & Grotta, J. C. (2011) · Annals of Neurology · doi:10.1002/ana.22458 · Cited by 291
Shen, L. H., Li, Y., Chen, J., Zhang, J., Vanguri, P., Borneman, J., & Chopp, M. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2005.08.092 · Cited by 286
Onda, T., Honmou, O., Harada, K., Houkin, K., Hamada, H., & Kocsis, J. D. (2008) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600527 · Cited by 238
Honma, T., Honmou, O., Iihoshi, S., Harada, K., Houkin, K., Hamada, H., & Kocsis, J. D. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2005.05.004 · Cited by 230
Leu, S., Lin, Y.-C., Yuen, C.-M., Yen, C.-H., Kao, Y.-H., Sun, C.-K., & Yip, H.-K. (2010) · Journal of Translational Medicine · doi:10.1186/1479-5876-8-63 · Cited by 220
One-year follow-up after bone marrow stromal cell treatment in middle-aged female rats with stroke
Shen, L. H., Li, Y., Chen, J., Cui, Y., Zhang, C., Kapke, A., Lu, M., Savant-Bhonsale, S., & Chopp, M. (2007) · Stroke · doi:10.1161/strokeaha.106.481218 · Cited by 208
van Koppen, A., Joles, J. A., van Balkom, B. W. M., Lim, S. K., de Kleijn, D., Giles, R. H., & Verhaar, M. C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038746 · Cited by 204
Optimizing the success of cell transplantation therapy for stroke
Bliss, T. M., Andres, R. H., & Steinberg, G. K. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.10.003 · Cited by 184
Dlouhy, B. J., Awe, O., Rao, R. C., Kirby, P. A., & Hitchon, P. W. (2014) · Journal of Neurosurgery: Spine · doi:10.3171/2014.5.spine13992 · Cited by 175
Leong, W. K., Henshall, T. L., Arthur, A., Kremer, K. L., Lewis, M. D., Helps, S. C., Field, J., Hamilton-Bruce, M. A., Warming, S., Manavis, J., et al. (2012) · Stem Cells Translational Medicine · doi:10.5966/sctm.2011-0039 · Cited by 173
Stem cell therapy: A clinical trial of stroke
Bhasin, A., Padma Srivastava, M. V., Mohanty, S., Bhatia, R., Kumaran, S. S., & Bose, S. (2013) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2012.10.015 · Cited by 170
Autologous Mesenchymal Stem Cells in Chronic Stroke
Bhasin, A., Srivastava, M. V. P., Kumaran, S. S., Mohanty, S., Bhatia, R., Bose, S., Gaikwad, S., Garg, A., & Airan, B. (2011) · Cerebrovascular Diseases Extra · doi:10.1159/000333381 · Cited by 168
Yoo, S.-W., Kim, S.-S., Lee, S.-Y., Lee, H.-S., Kim, H.-S., Lee, Y.-D., & Suh-Kim, H. (2008) · Experimental and Molecular Medicine · doi:10.3858/emm.2008.40.4.387 · Cited by 168
Bone marrow-derived mesenchymal stem cells for the treatment of ischemic stroke
Dharmasaroja, P. (2008) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2008.05.006 · Cited by 166
Doeppner, T. R., Doehring, M., Bretschneider, E., Zechariah, A., Kaltwasser, B., Müller, B., Koch, J. C., Bähr, M., Hermann, D. M., & Michel, U. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1142-5 · Cited by 164
Self-citationJanowski, M., Lyczek, A., Engels, C. C., Xu, J., Łukomska, B., Bulte, J. W. M., & Walczak, P. (2013) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2013.32 · Cited by 156
Hematopoietic Stem Cells Reduce Postischemic Inflammation and Ameliorate Ischemic Brain Injury
Schwarting, S., Litwak, S. A., Hao, W., Bähr, M., Weise, J., & Neumann, H. (2008) · Stroke · doi:10.1161/strokeaha.108.513978 · Cited by 154
The tumorigenicity of diploid and aneuploid human pluripotent stem cells
Blum, B., & Benvenisty, N. (2009) · Cell Cycle · doi:10.4161/cc.8.23.10067 · Cited by 146
Yoo, S., Chang, D., Lee, H. S., Kim, G., Park, J., Ryu, B., Joe, E.-H., Lee, Y., Kim, S., & Suh‐Kim, H. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.06.001 · Cited by 126
Famakin, B. M. (2014) · Aging and Disease · doi:10.14336/ad.2014.0500307 · Cited by 125
Suppressing Immunosuppression after Stroke
Meisel, C., & Meisel, A. (2011) · New England Journal of Medicine · doi:10.1056/nejmcibr1112454 · Cited by 122
Mesenchymal Stem Cells Derived from Peripheral Blood Protects against Ischemia
Ukai, R., Honmou, O., Harada, K., Houkin, K., Hamada, H., & Kocsis, J. D. (2007) · Journal of Neurotrauma · doi:10.1089/neu.2006.0161 · Cited by 118
Therapeutic time window of mesenchymal stem cells derived from bone marrow after cerebral ischemia
Komatsu, K., Honmou, O., Suzuki, J., Houkin, K., Hamada, H., & Kocsis, J. D. (2010) · Brain Research · doi:10.1016/j.brainres.2010.04.006 · Cited by 108
Doeppner, T. R., Kaltwasser, B., Bähr, M., & Hermann, D. M. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00338 · Cited by 102
Self-citationSheikh, A. M., Nagai, A., Wakabayashi, K., Narantuya, D., Kobayashi, S., Yamaguchi, S., & Kim, S. U. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.12.009 · Cited by 101
Zheng, W., Honmou, O., Miyata, K., Harada, K., Suzuki, J., Liu, H., Houkin, K., Hamada, H., & Kocsis, J. D. (2009) · Brain Research · doi:10.1016/j.brainres.2009.11.012 · Cited by 95
Functional Status of Peripheral Blood T-Cells in Ischemic Stroke Patients
Vogelgesang, A., May, V. E. L., Grunwald, U., Bakkeboe, M., Langner, S., Wallaschofski, H., Kessler, C., Bröker, B. M., & Dressel, A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008718 · Cited by 93
Mitkari, B., Kerkelä, E., Nystedt, J. M., Korhonen, M. O., Mikkonen, V., Huhtala, T., & Jolkkonen, J. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.09.018 · Cited by 83
Doeppner, T. R., Ewert, T. A. S., Tönges, L., Herz, J., Zechariah, A., ElAli, A., Ludwig, A., Giebel, B., Nagel, F., Dietz, G. P. H., et al. (2012) · Stem Cells · doi:10.1002/stem.1098 · Cited by 82
Self-citationChung, D., Choi, C., Lee, S., Kang, E., Lee, J., Hwang, S., Han, H. J., Lee, J., Choe, B., Lee, S., et al. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.22162 · Cited by 81
Tate, C. C., Fonck, C., McGrogan, M. P., & Case, C. C. (2010) · Cell Transplantation · doi:10.3727/096368910x494885 · Cited by 77
Scheibe, F., Klein, O., Klose, J., & Priller, J. (2012) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-012-9798-2 · Cited by 71
The potential benefit of stem cell therapy after stroke: an update
Banerjee, S., Chataway, Williamson, D. A., & Habib, N. (2012) · Vascular Health and Risk Management · doi:10.2147/vhrm.s25745 · Cited by 60
Sleuthing the Source of Regeneration by MSCs
Pittenger, M. F. (2009) · Cell stem cell · doi:10.1016/j.stem.2009.06.013 · Cited by 59
Herz, J., Hagen, S. I., Bergmüller, E., Sabellek, P., Göthert, J. R., Buer, J., Hansen, W., Hermann, D. M., & Doeppner, T. R. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.10.022 · Cited by 57
Self-citationDoeppner, T. R., Kaltwasser, B., Teli, M. K., Bretschneider, E., Bähr, M., & Hermann, D. M. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.359 · Cited by 54
Self-citationDoeppner, T. R., & Hermann, D. M. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00357 · Cited by 47
Self-citationMesenchymal stem cells in the treatment of ischemic stroke: progress and possibilities
Doeppner, T. R., & Hermann, D. M. (2010) · Stem Cells and Cloning Advances and Applications · doi:10.2147/sccaa.s7820 · Cited by 44
Self-citationStem Cells for Enhancing Recovery after Stroke: A Review
England, T. J., Martin, P. B., & Bath, P. M. (2009) · International Journal of Stroke · doi:10.1111/j.1747-4949.2009.00253.x · Cited by 24
Cited by
Concise review: MSC-derived exosomes for cell-free therapy
Phinney, D. G., & Pittenger, M. F. (2017) · Stem Cells · doi:10.1002/stem.2575 · Cited by 1,834
Applying extracellular vesicles based therapeutics in clinical trials – an ISEV position paper
Lener, T., Gimona, M., Aigner, L., Börger, V., Buzas, E., Camussi, G., Chaput, N., Chatterjee, D., Court, F. A., del Portillo, H. A., et al. (2015) · Journal of Extracellular Vesicles · doi:10.3402/jev.v4.30087 · Cited by 1,491
Self-citationGurunathan, S., Kang, M.-H., Jeyaraj, M., Qasim, M., & Kim, J.-H. (2019) · Cells · doi:10.3390/cells8040307 · Cited by 1,122
Exosomes: Therapy delivery tools and biomarkers of diseases
Barile, L., & Vassalli, G. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.02.020 · Cited by 1,038
Mesenchymal stem cell-derived extracellular vesicles: novel frontiers in regenerative medicine
Keshtkar, S., Azarpira, N., & Ghahremani, M. H. (2018) · Stem Cell Research & Therapy · doi:10.1186/s13287-018-0791-7 · Cited by 907
Metadata
- Authors
- Doeppner, T. R., Herz, J., Görgens, A., Schlechter, J., Ludwig, A.-K., Radtke, S., de Miroschedji, K., Horn, P. A., Giebel, B., & Hermann, D. M.
- Venue
- Stem Cells Translational Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-09-03
- Volume
- 4
- Issue
- 10
- Pages
- 1131-1143
- ISSN
- 2157-6564 (ISSN-L)
- 2157-6580
- OpenAlex
- W2177788064
- Cited by
- 772
- References
- 71
- FWCI
- 18.65
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.